Annual CAPEX
$921.00 K
-$839.00 K-47.67%
December 31, 2023
Summary
- As of February 7, 2025, PLRX annual capital expenditures is $921.00 thousand, with the most recent change of -$839.00 thousand (-47.67%) on December 31, 2023.
- During the last 3 years, PLRX annual CAPEX has fallen by -$611.00 thousand (-39.88%).
- PLRX annual CAPEX is now -52.84% below its all-time high of $1.95 million, reached on December 31, 2021.
Performance
PLRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- PLRX quarterly capital expenditures is not available.
Performance
PLRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- PLRX TTM capital expenditures is not available.
Performance
PLRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
PLRX CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -47.7% | - | - |
3 y3 years | -39.9% | - | - |
5 y5 years | - | - | - |
PLRX CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -52.8% | at low | ||||
5 y | 5-year | -52.8% | at low | ||||
alltime | all time | -52.8% | at low |
Pliant Therapeutics CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $921.00 K(-47.7%) | - | - |
Jun 2023 | - | $603.00 K(+269.9%) | $1.63 M(+27.3%) |
Mar 2023 | - | $163.00 K(-1.8%) | $1.28 M(-27.3%) |
Dec 2022 | $1.76 M(-9.9%) | $166.00 K(-76.1%) | $1.76 M(-19.5%) |
Sep 2022 | - | $696.00 K(+174.0%) | $2.19 M(+11.0%) |
Jun 2022 | - | $254.00 K(-60.6%) | $1.97 M(-16.3%) |
Mar 2022 | - | $644.00 K(+8.8%) | $2.35 M(+20.6%) |
Dec 2021 | $1.95 M | $592.00 K(+23.3%) | $1.95 M(+0.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $480.00 K(-24.9%) | $1.95 M(+8.8%) |
Jun 2021 | - | $639.00 K(+164.0%) | $1.79 M(+24.5%) |
Mar 2021 | - | $242.00 K(-58.8%) | $1.44 M(-6.1%) |
Dec 2020 | $1.53 M(+58.9%) | $587.00 K(+81.7%) | $1.53 M(+35.7%) |
Sep 2020 | - | $323.00 K(+12.9%) | $1.13 M(+40.1%) |
Jun 2020 | - | $286.00 K(-14.9%) | $806.00 K(+55.0%) |
Mar 2020 | - | $336.00 K(+82.6%) | $520.00 K(+182.6%) |
Dec 2019 | $964.00 K | $184.00 K | $184.00 K |
FAQ
- What is Pliant Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Pliant Therapeutics?
- What is Pliant Therapeutics annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Pliant Therapeutics?
- What is the all time high TTM CAPEX for Pliant Therapeutics?
What is Pliant Therapeutics annual capital expenditures?
The current annual CAPEX of PLRX is $921.00 K
What is the all time high annual CAPEX for Pliant Therapeutics?
Pliant Therapeutics all-time high annual capital expenditures is $1.95 M
What is Pliant Therapeutics annual CAPEX year-on-year change?
Over the past year, PLRX annual capital expenditures has changed by -$839.00 K (-47.67%)
What is the all time high quarterly CAPEX for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly capital expenditures is $696.00 K
What is the all time high TTM CAPEX for Pliant Therapeutics?
Pliant Therapeutics all-time high TTM capital expenditures is $2.35 M